Awakn Life Sciences Corp.

CNSX:AWKN Stock Report

Market Cap: CA$4.6m

Awakn Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Anthony Tennyson

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership4.9%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Anthony Tennyson's remuneration changed compared to Awakn Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$3m

Apr 30 2024n/an/a

-CA$4m

Jan 31 2024n/an/a

-CA$4m

Oct 31 2023n/an/a

-CA$3m

Jul 31 2023n/an/a

-CA$3m

Apr 30 2023n/an/a

-CA$3m

Jan 31 2023CA$311kCA$240k

-CA$5m

Oct 31 2022n/an/a

-CA$8m

Jul 31 2022n/an/a

-CA$10m

Apr 30 2022n/an/a

-CA$18m

Jan 31 2022CA$348kCA$220k

-CA$16m

Oct 31 2021n/an/a

-CA$13m

Jan 31 2021CA$72kCA$52k

-CA$1m

Compensation vs Market: Insufficient data to establish whether Anthony's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Anthony's compensation has been consistent with company performance over the past year.

CEO

Anthony Tennyson

4.4yrs

Tenure

CA$311,400

Compensation

Mr. Anthony Tennyson is a Co-founder and has been President & Chief Executive Officer of Awakn Life Sciences Corp. since June 1, 2020 and has been its Director since May 21, 2020. Mr. Tennyson serves as Ex...

Board Members

NamePositionTenureCompensationOwnership
George Scorsis
Co-founder & Chairman of the Board4.5yrsCA$34.26k2.71%
CA$ 124.4k
Anthony Tennyson
Co-founder4.5yrsCA$311.40k4.85%
CA$ 222.5k
David Nutt
Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer3.4yrsno data0.34%
CA$ 15.4k
Barbara Mason
Member of Clinical Advisory Board3.3yrsno datano data
Paul Rutherford Carter
Independent Director2.9yrsCA$48.85kno data
Shaun McNulty
Member of Pre-Clinical Advisory Board3.3yrsCA$241.21kno data
Stephen Page
Independent Non Executive Director3.6yrsCA$18.76k0.16%
CA$ 7.5k
John Papastergiou
Independent Non Executive Director3.6yrsCA$18.76k0.094%
CA$ 4.3k
Kevin Fone
Member of Pre-Clinical Advisory Board3.3yrsno datano data
Harriet de Wit
Member of Pre-Clinical Advisory Board3.3yrsno datano data
Stephen Husbands
Member of Pre-Clinical Advisory Board3.3yrsno datano data

3.3yrs

Average Tenure

Experienced Board: AWKN's board of directors are considered experienced (3.3 years average tenure).